1. Home
  2. ASND vs QRVO Comparison

ASND vs QRVO Comparison

Compare ASND & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • QRVO
  • Stock Information
  • Founded
  • ASND 2006
  • QRVO 1957
  • Country
  • ASND Denmark
  • QRVO United States
  • Employees
  • ASND N/A
  • QRVO N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • QRVO Semiconductors
  • Sector
  • ASND Health Care
  • QRVO Technology
  • Exchange
  • ASND Nasdaq
  • QRVO Nasdaq
  • Market Cap
  • ASND 8.8B
  • QRVO 10.5B
  • IPO Year
  • ASND 2015
  • QRVO 1997
  • Fundamental
  • Price
  • ASND $126.66
  • QRVO $104.28
  • Analyst Decision
  • ASND Strong Buy
  • QRVO Hold
  • Analyst Count
  • ASND 13
  • QRVO 17
  • Target Price
  • ASND $195.00
  • QRVO $119.88
  • AVG Volume (30 Days)
  • ASND 537.5K
  • QRVO 1.2M
  • Earning Date
  • ASND 11-05-2024
  • QRVO 10-29-2024
  • Dividend Yield
  • ASND N/A
  • QRVO N/A
  • EPS Growth
  • ASND N/A
  • QRVO N/A
  • EPS
  • ASND N/A
  • QRVO N/A
  • Revenue
  • ASND $340,327,869.00
  • QRVO $4,005,013,000.00
  • Revenue This Year
  • ASND $16.12
  • QRVO $6.75
  • Revenue Next Year
  • ASND $87.44
  • QRVO $8.08
  • P/E Ratio
  • ASND N/A
  • QRVO N/A
  • Revenue Growth
  • ASND 166.54
  • QRVO 25.74
  • 52 Week Low
  • ASND $85.29
  • QRVO $80.62
  • 52 Week High
  • ASND $161.00
  • QRVO $130.99
  • Technical
  • Relative Strength Index (RSI)
  • ASND 38.86
  • QRVO 51.49
  • Support Level
  • ASND $125.40
  • QRVO $99.26
  • Resistance Level
  • ASND $132.63
  • QRVO $107.33
  • Average True Range (ATR)
  • ASND 4.46
  • QRVO 2.58
  • MACD
  • ASND -1.87
  • QRVO 0.63
  • Stochastic Oscillator
  • ASND 5.19
  • QRVO 63.16

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

Share on Social Networks: